About: Prevalence, Determinants of Positivity, and Clinical Utility of Cryptococcal Antigenemia in Cambodian HIV-Infected Patients

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Prevalence, Determinants of Positivity, and Clinical Utility of Cryptococcal Antigenemia in Cambodian HIV-Infected Patients Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article

Attributes	Values
rdf:type	Item
description	article (en) ലേഖനം (ml) wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 2007 (uk) im August 2007 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q56830151-986A9C58-E783-4218-BE42-569A6D48F314
publication date	2007-08-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q56830151-45B8546A-6F2E-4FF6-AE4B-A82033F376E7
language of work or name	English
author name string	wds:Q56830151-43986531-DEEE-4F4B-8970-A8AE079A3060 wds:Q56830151-704F8640-A786-49DC-9999-3710F7AD275E wds:Q56830151-83094FA5-F870-4EA8-B52A-6DD2B2B61174 wds:Q56830151-92E5590F-6C6E-4FA9-BE40-C1EF7AC1199F wds:Q56830151-A36330D2-4757-4B0F-AFC4-75967D0546D2 wds:Q56830151-A9D160F7-00AA-45EE-83C3-2B8018DBF3BC wds:Q56830151-D9D67417-42D3-40F6-8351-4CCE1964A60C
author name string	Borann Sar Jean-Philippe Dousset Laurent Ferradini Romain Micol Hak Chanroeun ChanChhaya Ngeth Fran??oise Dromer
rdfs:label	Prevalence, Determinants of Positivity, and Clinical Utility of Cryptococcal Antigenemia in Cambodian HIV-Infected Patients (en) Prevalence, Determinants of Positivity, and Clinical Utility of Cryptococcal Antigenemia in Cambodian HIV-Infected Patients (nl)
skos:prefLabel	Prevalence, Determinants of Positivity, and Clinical Utility of Cryptococcal Antigenemia in Cambodian HIV-Infected Patients (en) Prevalence, Determinants of Positivity, and Clinical Utility of Cryptococcal Antigenemia in Cambodian HIV-Infected Patients (nl)
name	Prevalence, Determinants of Positivity, and Clinical Utility of Cryptococcal Antigenemia in Cambodian HIV-Infected Patients (en) Prevalence, Determinants of Positivity, and Clinical Utility of Cryptococcal Antigenemia in Cambodian HIV-Infected Patients (nl)
author	wds:Q56830151-052A8E2E-484E-4135-A4B1-C298A5154720 wds:Q56830151-4A176D45-EFE8-4D8B-B0E6-386156A5E68D wds:Q56830151-70B5F329-4610-480A-86F7-03A62D099B86 wds:Q56830151-B5ED5070-2FA9-4BAF-95C7-4423DC6929E2
author	Philippe J. Guerin Arnaud Fontanet Olivier Lortholary Didier Laureillard
title	wds:Q56830151-5111837E-4E9E-420E-B106-BCA132BB988C
title	Prevalence, Determinants of Positivity, and Clinical Utility of Cryptococcal Antigenemia in Cambodian HIV-Infected Patients (en)
page(s)	wds:Q56830151-1FEDAEE5-73A6-4B11-A902-58D20F106C7D
page(s)	555-559
instance of	wds:Q56830151-E039BE49-C851-4A33-B890-A98AEF92EF9A
instance of	scholarly article
main subject	wds:Q56830151-814F4191-3ECD-4FC9-9F20-BC906C7499C1
main subject	Patients
PubMed ID	wds:Q56830151-AA030FF1-F68D-471A-AF33-EA6495CD9654
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17577124
PubMed ID	17577124
published in	wds:Q56830151-45F58D2C-1A5B-430B-BF4F-BA9F1970E73D
published in	Journal of Acquired Immune Deficiency Syndromes
issue	wds:Q56830151-D0595C84-718B-4579-9E1D-C23B9D17AF12
volume	wds:Q56830151-55CD4B25-A4DB-404B-A963-3A589BD5C9C0
issue	5
volume	45
number of pages	wds:Q56830151-79FAED72-54F0-49E8-BDFD-7DABC4CC8444
number of pages	5 (xsd:decimal)
DOI	wds:Q56830151-E84FD33D-5619-4219-8721-A1B4D9D6F3E6
DOI	http://dx.doi.org/10.1097/QAI.0B013E31811ED32C
DOI	10.1097/QAI.0B013E31811ED32C
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q56830151
is cites work of	Cost-effectiveness of primary prophylaxis of AIDS associated cryptococcosis in Cambodia Evaluation of a rapid lateral flow immunoassay for the detection of cryptococcal antigen for the early diagnosis of cryptococcosis in HIV patients in Colombia New Insights into HIV/AIDS-Associated Cryptococcosis Cryptococcal antigen screening and preemptive therapy in patients initiating antiretroviral therapy in resource-limited settings: a proposed algorithm for clinical implementation Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa CrAg lateral flow assay for cryptococcosis Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings Integrating cryptococcal antigen screening and pre-emptive treatment into routine HIV care Major role for amphotericin B-flucytosine combination in severe cryptococcosis Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Universal screening of Tanzanian HIV-infected adult inpatients with the serum cryptococcal antigen to improve diagnosis and reduce mortality: an operational study Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy Cryptococcal Antigenemia in Immunocompromised Human Immunodeficiency Virus Patients in Rural Tanzania: A Preventable Cause of Early Mortality Gender specific differences in the immune response to infection Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986-2012. Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions Cryptococcal infections: changing epidemiology and implications for therapy. Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa The impact of routine cryptococcal antigen screening on survival among HIV-infected individuals with advanced immunosuppression in Kenya Asymptomatic cryptococcemia in resource-limited settings Asymptomatic cryptococcal antigenemia is associated with mortality among HIV-positive patients in Indonesia Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen Prevalence and outcomes of cryptococcal antigenemia in HIV-seropositive patients hospitalized for suspected tuberculosis in Uganda High prevalence of cryptococcal infection among HIV-infected patients hospitalized with pneumonia in Thailand. High prevalence of Cryptococcal antigenemia among HIV-infected patients receiving antiretroviral therapy in Ethiopia Prevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda: a cross-sectional study Screening for cryptococcal antigenemia in anti-retroviral naïve AIDS patients in benin city, Nigeria Estimated Prevalence of Cryptococcus Antigenemia (CrAg) among HIV-Infected Adults with Advanced Immunosuppression in Namibia Justifies Routine Screening and Preemptive Treatment Comparison of cryptococcal antigenemia between antiretroviral naïve and antiretroviral experienced HIV positive patients at two hospitals in Ethiopia Treatment of cryptococcal meningitis in resource limited settings Prevalence of cryptococcal antigenemia and cost-effectiveness of a cryptococcal antigen screening program--Vietnam Treatment of cryptococcosis in the setting of HIV coinfection. Central nervous system immune reconstitution inflammatory syndrome. Comment on "cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda (Oyella et al. 2012)" Preventing Cryptococcosis-Shifting the Paradigm in the Era of Highly Active Antiretroviral Therapy Molecular diagnosis of invasive mycoses of the central nervous system Acute/subacute cerebral infarction (ASCI) in HIV-negative adults with cryptococcal meningoencephalitis (CM): a MRI-based follow-up study and a clinical comparison to HIV-negative CM adults without ASCI.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software